Michael Bourque serves as the Executive Vice President, Chief Financial Officer, and Corporate Treasurer at INOGEN INC, a leading medical technology company specializing in innovative respiratory products. With over two decades of experience in financial management and strategic planning, Bourque has played a pivotal role in steering INOGEN INC towards sustained growth and profitability. His expertise in financial operations and corporate strategy has been instrumental in enhancing the company's market position and operational efficiency. Prior to joining INOGEN INC, Bourque held several senior financial positions at notable organizations, where he honed his skills in financial planning, analysis, and investor relations. His career trajectory includes significant roles at companies such as Beckman Coulter, where he served as Vice President of Finance, and at Alphatec Spine, where he was the Chief Financial Officer. These experiences equipped him with a deep understanding of the healthcare and medical technology sectors, enabling him to effectively manage INOGEN INC's financial health and strategic initiatives. At INOGEN INC, Bourque's responsibilities encompass overseeing the company's financial strategy, which includes managing capital allocation, financial reporting, and risk management. Under his leadership, INOGEN INC has successfully navigated complex market dynamics and regulatory environments, achieving robust financial performance and expanding its global footprint. Bourque's strategic vision and financial acumen continue to drive the company's mission to improve the quality of life for patients with respiratory conditions through innovative and accessible solutions.